Replay: Expert Access: Barclays Hosted KOL Call: Obesity Coverage Comes to Medicare - How Is It Going To Work?

Research evidence excerpt

Replay: Expert Access: Barclays Hosted KOL Call: Obesity Coverage Comes to Medicare - How Is It Going To Work?

Equity Research

30 June 2026

Replay: Expert Access

Barclays Hosted KOL Call: Obesity

Coverage Comes to Medicare -

How Is It Going To Work? U.S. Biopharmaceuticals

Emily Field, CFA

We hosted Eric Katz for a KOL call to discuss the upcoming +1 212 526 4160

rollout of GLP-1 obesity coverage for US Medicare emily.field@barclays.com

BCI, US

beneficiaries. Within our coverage, we discussed implications

for LLY (US pharma), NOVOB (EU pharma) and HUM (US EuropeanBiotechnologyPharmaceuticals,& Life Sciences

James Gordonmanaged care).

+44 (0)20 7116 2784

james.gordon@barclays.com

Barclays, UK

Please see below replay information for the event held on

U.S. Healthcare Facilities & Managed Monday, 29 June 2026 at 10:00am – 11:00am New York

Care

This replay is strictly and solely for the benefit of the intended recipients. Barclays Events Terms of Andrew Mok, CFA

Service and the Barclays Events Privacy Notice +1 212 526 5496

andrew.mok@barclays.com

Watch

This transcript/recording is provided in an unedited format. Barclays is not responsible for the

recording quality or any transcription errors or omissions.

With Medicare coverage for obesity medications scheduled to come online on July 1st, we

hosted a KOL call with Eric Katz, a Washington-based health policy expert who spent 10

Appearances by Third-Party Speakers: Any views or opinions expressed by third-party speakers

during this event are solely those of the speaker and do not represent the views or opinions of

Barclays. Barclays is not responsible for, and makes no warranties whatsoever as to, the

information or opinions contained in any written, electronic, audio or video presentations by any